| Financial Year |
March 31 2023 |
| Monetary Funds |
3,810,385,603.05 |
| Held-for-trading Financial Assets |
2,188,035,009.83 |
| Notes Receivable |
565,462,417.21 |
| Accounts Receivable |
11,159,906,705.20 |
| Advances to Suppliers |
977,177,929.22 |
| Other Receivables |
523,607,827.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
14,937.73 |
| Inventories |
4,074,374,916.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,003,196,211.51 |
| Total Current Assets |
29,031,467,054.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,391,247.30 |
| Long-term Equity Investment |
131,946,353.23 |
| Investment Properties |
138,375,603.76 |
| Fixed Assetes |
3,950,385,523.10 |
| Under-construction Projects |
340,152,837.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,826,178,028.23 |
| R&D expenses |
272,880,077.81 |
| Goodwill |
24,402,443.88 |
| Long-Term Deferred and Prepaid Expenses |
12,252,086.81 |
| Deferred Income Tax Assets |
474,949,936.02 |
| Other Non-Current Assets |
1,861,546,938.59 |
| Sub-Total of Non-Current Assets |
10,932,914,136.18 |
| Total Assets |
39,964,381,191.13 |
| Short-Term Loans |
699,346,520.21 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,446,431,471.22 |
| Accounts Payable |
7,031,660,696.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
91,064,147.89 |
| Taxes Payable |
249,019,131.77 |
| Interest Payable |
-- |
| Dividend Payable |
13,582,807.44 |
| Other payables |
534,374,443.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
47,485,434.56 |
| Other Current Liabilities |
1,047,953,029.07 |
| Sub-Total of Current Liabilities |
15,378,644,807.01 |
| Long-term Loans |
57,200,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
403,850,804.22 |
| Special Payable |
-- |
| Estimatied Liabilities |
26,240,787.67 |
| Deferred Income Tax Liabilities |
125,451,597.39 |
| Other Non-Current Liabilities |
516,925.31 |
| Sub-Total of Non-Current Liabilities |
1,345,227,940.53 |
| Total Liabilities |
16,723,872,747.54 |
| Paid-In Capital(Or Share Stock) |
5,125,882,352.00 |
| Capital Surplus |
12,007,133,646.30 |
| Surplus Reserve |
616,668,279.52 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,345,023,039.44 |
| Minority Stockholder's Interest |
1,942,003,711.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
21,298,504,731.96 |
| Owner's Equity（Stockholder's Equity） |
23,240,508,443.59 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
39,964,381,191.13 |
